| Originalspråk | engelska |
|---|---|
| Tidskrift | Blood |
| Volym | 116 |
| Utgåva | 21 |
| Sidor (från-till) | 1281-1281 |
| Antal sidor | 1 |
| ISSN | 0006-4971 |
| Status | Publicerad - 19 nov 2010 |
| Evenemang | 52nd Annual Meeting of the American-Society-of-Hematology (ASH) - Orlando Varaktighet: 4 dec 2010 → 7 dec 2010 |
Citera det här
}
Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study. / Koivula, Satu; Taskinen, Minna; Chen, Ping; Holte, Harald; Delabie, Jan; Karjalainen-Lindsberg, Marja-Liisa; Bjorkholm, Magnus; Fluge, Oystein; Pedersen, Lars Moller; Jerkeman, Mats; Eriksson, Mikael; Hautaniemi, Sampsa; Leppa, Sirpa.
I: Blood, Vol. 116, Nr. 21, 19.11.2010, s. 1281-1281.Forskningsoutput: Tidskriftsbidrag › Mötesabstrakt › Forskning › Peer review
TY - JOUR
T1 - Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study.
AU - Koivula, Satu
AU - Taskinen, Minna
AU - Chen, Ping
AU - Holte, Harald
AU - Delabie, Jan
AU - Karjalainen-Lindsberg, Marja-Liisa
AU - Bjorkholm, Magnus
AU - Fluge, Oystein
AU - Pedersen, Lars Moller
AU - Jerkeman, Mats
AU - Eriksson, Mikael
AU - Hautaniemi, Sampsa
AU - Leppa, Sirpa
PY - 2010/11/19
Y1 - 2010/11/19
M3 - Meeting Abstract
VL - 116
SP - 1281
EP - 1281
JO - Blood
JF - Blood
SN - 0006-4971
IS - 21
ER -